Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Advances in Spatial Genomics » Breast Cancer Risk Clues Found By Sequencing Cells From BRCA2 Germline Mutation Carriers

Breast Cancer Risk Clues Found By Sequencing Cells From BRCA2 Germline Mutation Carriers

Jan 29, 2020
|
staff reporter

NEW YORK – With the help of single-cell sequencing, a team from Massachusetts General Hospital and elsewhere has identified key alterations that may contribute to breast cancer development in individuals with one risky copy of the BRCA2 gene.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Stricter Vaccine Standards

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Another Trial to Ramp Up

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Few Billion More

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
06
Featured Webinar

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure. 

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
13
Featured Webinar

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

Sponsored by
Lexogen

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

What's Popular?

In Sequencing

  1. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

    Premium

  2. Google DeepVariant Boosts Accuracy of Indel Calls in PacBio Long Reads

    Premium

  3. UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

  4. Genome Sequencing Boosts Diagnostic Yield in Children With Unexplained Medical Complexity

  5. Illumina to Acquire Grail for $8B in Cash and Stock

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.